Follow-up of endometrial cancer

被引：0

作者：

Gauthier, Tristan ^{[1
]}

Siegerth, Francois ^{[1
]}

Monteil, Jacques ^{[2
]}

Jammet, Isabelle ^{[3
]}

Saidi, Nadira ^{[4
]}

Tubiana-Mathieu, Nicole ^{[5
]}

Aubard, Yves ^{[1
]}

机构：

[1] CHU Limoges, HME, Serv Gynecol Obstet, F-87000 Limoges, France

[2] CHU Limoges, Serv Med Nucl, F-87000 Limoges, France

[3] CHU Limoges, Serv Imagerie Med, F-87000 Limoges, France

[4] CHU Limoges, Serv Radiotherapie, F-87000 Limoges, France

[5] CHU Limoges, Serv Oncol Med, F-87000 Limoges, France

来源：

BULLETIN DU CANCER | 2014年 / 101卷 / 7-8期

关键词：

cancer; endometrial; uterus; follow-up; recurrence; GYNECOLOGIC-ONCOLOGY-GROUP; POST-THERAPY SURVEILLANCE; PHASE-III TRIAL; FDG-PET/CT; STAGE-I; POSTTREATMENT SURVEILLANCE; COST-EFFECTIVENESS; RADIATION-THERAPY; VAGINAL CYTOLOGY; RANDOMIZED-TRIAL;

D O I：

10.1684/bdc.2014.1947

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Available data on appropriate follow-up in endometrial cancer highlight the need of well-conducted studies. Most recurrences tend to occur within three years and involve symptoms. Routine tests are not,advocated without symptoms. In case of suspicious recurrence, TEP/CT seems to be the most sensitive and specific method. There is limited evidence to decide whether follow-up schedules with multiple visits result in survival benefits. An appropriate follow-up should be discussed based upon the risk of recurrence. Counselling on the potential symptoms of recurrence should be a major aim.

引用

页码：741 / 747

页数：7

共 50 条

[21] Follow-up after primary therapy for endometrial cancer: A systematic review
Fung-Kee-Fung, Michael
Dodge, Jason
Elit, Laurie
Lukka, Himu
Chambers, Alex
Oliver, Tom
GYNECOLOGIC ONCOLOGY, 2006, 101 (03) : 520 - 529
[22] ACR Appropriateness Criteria\Pretreatment Evaluation and Follow-Up of Endometrial Cancer
Lalwani, Neeraj
Dubinsky, Theodore
Javitt, Marcia C.
Gaffney, David K.
Glanc, Phyllis
Elshaikh, Mohamed A.
Kim, Young Bae
Lee, Larissa J.
Pannu, Harpreet K.
Royal, Henry D.
Shipp, Thomas D.
Siegel, Cary Lynn
Simpson, Lynn
Wahl, Andrew O.
Wolfson, Aaron H.
Zelop, Carolyn M.
ULTRASOUND QUARTERLY, 2014, 30 (01) : 21 - 28
[23] Endometrial Carcinoma Follow-up: Time for a Change?
Saxby, H.
Tailor, A.
Essapen, S.
CLINICAL ONCOLOGY, 2019, 31 (04) : 267 - 267
[24] Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers
Milagros Otero-Garcia, Maria
Mesa-Alvarez, Alicia
Nikolic, Olivera
Blanco-Lobato, Patricia
Basta-Nikolic, Marijana
Menendez de Llano-Ortega, Rafael
Paredes-Velazquez, Laura
Nikolic, Nikola
Szewczyk-Bieda, Magda
INSIGHTS INTO IMAGING, 2019, 10 (01)
[25] Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
K Lindemann
L J Vatten
M Ellstrøm-Engh
A Eskild
British Journal of Cancer, 2008, 98 : 1582 - 1585
[26] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Plataniotis, G.
Castiglione, M.
ANNALS OF ONCOLOGY, 2010, 21 : v41 - v45
[27] Patient initiated follow-up (PIFU) in low-risk endometrial cancer
Shahreen, S.
Marouli, M.
Graham, R.
MacDonald, N.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 52 - 52
[28] Costs and benefits of routine follow-up after curative treatment for endometrial cancer
Agboola, OO
Grunfeld, E
Coyle, D
Perry, GA
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1997, 157 (07) : 879 - 886
[29] ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer of the Uterus
Lee, Jean Hwa
Dubinsky, Theodore
Andreotti, Rochelle F.
Cardenes, Higinia Rosa
Allison, Sandra O. DeJesus
Gaffney, David K.
Glanc, Phyllis
Horowitz, Neil S.
Jhingran, Anuja
Lee, Susanna I.
Puthawala, Ajmel A.
Royal, Henry D.
Scoutt, Leslie M.
Small, William, Jr.
Varia, Mahesh A.
Zelop, Carolyn M.
ULTRASOUND QUARTERLY, 2011, 27 (02) : 139 - 145
[30] Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
Lindemann, K.
Vatten, L. J.
Ellstrom-Engh, M.
Eskild, A.
BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1582 - 1585

← 1 2 3 4 5 →